| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $32K | — | +1500.0% |
| R&D Expense | $1.4M | — | +132.2% |
| SG&A Expense | $1.4M | — | +30.1% |
| Operating Income | -$2.7M | — | -66.6% |
| Pre-tax Income | -$2.7M | — | -57.5% |
| Net Income | -$2.7M | — | -57.5% |
| EPS (Basic) | $0.85 | — | +226.9% |
| EPS (Diluted) | $0.85 | — | +226.9% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $2.4M | -59.7% | -60.8% |
| Current Assets | $4.1M | -38.8% | -47.4% |
| Total Assets | $4.6M | -36.2% | -44.6% |
| Current Liabilities | $4.1M | +47.2% | +69.5% |
| Total Liabilities | $4.3M | -6.5% | -24.7% |
| Stockholders' Equity | $291K |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$3.6M | — | -48.6% |
| Capital Expenditures | $0 | — | -100.0% |
| Investing Cash Flow | $0 | — | +100.0% |
| Financing Cash Flow | $83K | — | -98.9% |
| Free Cash Flow | -$3.6M | — | -48.3% |
| -88.7% |